Skip to main content

About Us

The Corporate Relations service looks to assist Feinberg faculty and industry to achieve their shared goals through strong, mutually beneficial partnerships.

Duo Wang, PhD

Jeff Masters

Associate Dean for Corporate Partnerships

Dr. Wang brings over 20 years of industry experience spanning biopharmaceuticals, medical devices, diagnostics, and management consulting. She has held senior strategy and innovation roles at Abbott, Stryker, Medtronic, and IQVIA, leading corporate strategy, portfolio investments, external partnerships, and commercialization initiatives. Her experience spans the full innovation lifecycle, from identifying emerging technologies and shaping R&D investments to developing commercialization strategies and launching innovative healthcare products. Dr. Wang earned her PhD in Neuroscience from Harvard University, where she conducted pioneering research on RNA interference and gene regulation in the laboratory of Nobel laureate Dr. Gary Ruvkun. She has published in leading scientific journals, including two papers in Nature. She also holds a BS in Biophysics and Physiology from Peking University in Beijing, China.

Please contact Duo Wang at 312-503-1917.

Terry Nakagawa, PhD

Terry Nakagawa

Director of Corporate Partnerships and Business Development

Terry brings over 20 years of research leadership in academic and business organizations to the Feinberg Corporate Relations team. Her career spans across scientific entrepreneurship with biotech cell therapy startups (Dendreon, Geneius Biotechnology), large scale diagnostics manufacturing (Abbott Laboratories), and multidisciplinary research team management within global pharmaceutical drug discovery (Astellas Pharma). Terry received her BA from Northwestern University and her PhD in Immunology from Yale University with postdoctoral training at the University of Washington/HHMI. 

Please contact Terry Nakagawa at 312-503-5365.

About Feinberg Research

$758 Million

Feinberg received $758M in research funding and awards in 2026.

411,400

A total of 411,400 participants enrolled in clinical trials and research studies at Feinberg.

74%

Feinberg generates 74 percent of all research dollars at Northwestern University.

Foundation Relations

Northwestern University Feinberg School of Medicine offers assistance to private foundations looking to engage Feinberg researchers. Foundation Relations, led by Michelle Melin-Rogovin, senior associate director, supports Feinberg faculty in connecting with foundations in research that is mutually beneficial.

Visit Foundation Relations